FIM
VNDA icon

Freedom Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Freedom Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,943
Closed -$222K – 914
2021
Q3 		$222K Buy
12,943
+745
+6% +$13K 0.02% 728
2021
Q2 		$262K Buy
12,198
+1,465
+14% +$26.2K 0.02% 733
2021
Q1 		$161K Buy
+10,733
New +$174K 0.01% 805

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Freedom Investment Management's VNDA Position: Q4 2021 in Review

Freedom Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2021, closing a stake of 12,943 shares — an estimated $222K sold.

Freedom Investment Management first reported a position in VNDA in Q1 2021 and held it in 3 quarters. The position peaked at $262K in Q2 2021. 198 funds tracked by Wall St. Rank hold VNDA as of Q4 2021.

  • Freedom Investment Management reported no remaining Vanda Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Freedom Investment Management sold 12,943 Vanda Pharmaceuticals shares in Q4 2021, an estimated $222K.
  • Freedom Investment Management first reported a position in Vanda Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Freedom Investment Management's Vanda Pharmaceuticals position peaked at $262K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2021.

Based on Freedom Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.